October 6, 2009 – Siemens Healthcare announced the availability of syngo Dynamic PET with myocardial blood flow, a new cardiac imaging software application for the industry-leading Biograph PET/CT scanners that may have significant impact on the diagnosis of patients with advanced coronary artery disease (CAD) and specifically, with those patients with multivessel disease, or those who are asymp
October 6, 2009 – The Harvard Clinical Research Institute (HCRI) said last week the first patients are enrolled in the DAPT Study, marking the official initiation of the four-year clinical trial to investigate the duration of dual anti-platelet therapy (DAPT, the combination of aspirin and a thienopyridine/anti-platelet medication to reduce the risk of blood clots) following drug-eluting stent i
October 6, 2009 - Boston Scientific Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its WallFlex Biliary RX fully and partially covered stents for the palliative treatment of malignant bile duct strictures.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
October 6, 2009 – Direct Flow Medical Inc. released its One-year data from the initial clinical trial for its transcatheter prosthetic aortic valve during the recent Transcatheter Cardiovascular Therapeutics (TCT) 2009 meeting .
October 6, 2009 – New research shows magnetic interference from portable headphones has a clinically significant impact on the function of life-saving devices, according to a new study published in the October edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society.
October 6, 2009 – ProSolv CardioVascular, a Fujifilm company, recently said the Veterans in Partnership Healthcare Network (VISN 11) has extended its relationship with the company by contracting to add the Synapse ProSolv Cardiovascular solution in four additional hospitals.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 6, 2009 – Boston Scientific Corp. released data during TCT 2009 from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS Liberté Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.
The AMICAS One Suite of products provides a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided with a fully integrated, hospital information system-independent PACS that features advanced enterprise workflow support and scalable design. The suite includes the following tools:
October 5, 2009 – The National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) has awarded a grant to the American College of Cardiology (ACC) in partnership with the Society of Thoracic Surgeons (STS) to study the comparative effectiveness of the two forms of coronary revascularization – percutaneous coronary intervention (PCI) and coronary artery bypass graft (CAB
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 5, 2009 – A reduction in stroke was observed in patients with atrial fibrillation (AF) who received dronedarone (MULTAQ), according to a recent study published online in Circulation – “Analysis of Stroke in A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Caus
October 5, 2009 – Boston Scientific released its CE-marked, next-generation iLab System Software for the iLab Intravascular Ultrasound (IVUS) Imaging System during TCT 2009, which includes iMap tissue characterization, similar to Volcano’s Virtual Histology IVUS. The company said it is awaiting FDA clearance for the software.
October 5, 2009 – TomTec launched the vascular analysis solution M’Ath1 (Measure of Atherosclerosis) as a further part of TomTec’s CardioArena multimodality imaging program during the European Society of Cardiology congress 2009 in Barcelona.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 8, 2009 - At RSNA 2009 last week, Fujifilm introduced its Synapse cardiovascular version 4.0.4. This Web-based cardiovascular image and information management solution features additional third party integrations enabling clinicians to readily access relevant patient data stored in other locations.
AZE Ltd., a provider of advanced visualization solutions, provides 3D thin-client software Virtual Place distribution and technical support in North America.
October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine receptor agonist approved for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress, requires infrequent use of the drug aminophylline to reverse its effect in the case of adverse events.